FR2439233A1 - REAGENT ASSEMBLY AND METHOD FOR IDENTIFYING VIRAL INFECTIONS - Google Patents

REAGENT ASSEMBLY AND METHOD FOR IDENTIFYING VIRAL INFECTIONS

Info

Publication number
FR2439233A1
FR2439233A1 FR7926072A FR7926072A FR2439233A1 FR 2439233 A1 FR2439233 A1 FR 2439233A1 FR 7926072 A FR7926072 A FR 7926072A FR 7926072 A FR7926072 A FR 7926072A FR 2439233 A1 FR2439233 A1 FR 2439233A1
Authority
FR
France
Prior art keywords
viral infections
sample
identifying viral
cells
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7926072A
Other languages
French (fr)
Other versions
FR2439233B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of FR2439233A1 publication Critical patent/FR2439233A1/en
Application granted granted Critical
Publication of FR2439233B1 publication Critical patent/FR2439233B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

ENSEMBLE DE REACTIFS ET PROCEDE POUR L'IDENTIFICATION DES INFECTIONS VIRALES. ON PROCEDE A UNE IMMUNOREACTION D'UN ANTICORPS DIRIGE CONTRE UN VIRUS CONNU AVEC UN ECHANTILLON DE CELLULES INFECTEES IN VIVO, PUIS ON SEPARE L'ANTICORPS LIBRE DE L'ECHANTILLON, ON INCUBE L'ECHANTILLON AVEC DES BACTERIES CAPABLES DE SE FIXER A L'ANTICORPS ET ON ELIMINE LES BACTERIES NON FIXEES; UN ACCROISSEMENT DU NOMBRE DES BACTERIES FIXEES A LA SURFACE DES CELLULES PAR RAPPORT A UN TEMOIN QUI N'A PAS ETE MIS EN CONTACT AVEC L'ANTICORPS PERMET D'IDENTIFIER LES CELLULES INFECTEES PAR LE VIRUS CONNU. APPLICATION EN PARTICULIER AU DIAGNOSTIC SIMPLE ET RAPIDE DES INFECTIONS VIRALES.REAGENT SET AND METHOD FOR IDENTIFYING VIRAL INFECTIONS. AN IMMUNOREACTION OF AN ANTIBODY DIRECTED AGAINST A KNOWN VIRUS IS CARRIED OUT WITH A SAMPLE OF INFECTED CELLS IN VIVO, THEN THE FREE ANTIBODY IS SEPARATED FROM THE SAMPLE, THE SAMPLE IS INCUBATED WITH BACTERIES CAPABLE OF SEX. ANTIBODIES AND UNFIXED BACTERIA IS ELIMINATED; AN INCREASE IN THE NUMBER OF BACTERIA FIXED TO THE SURFACE OF THE CELLS COMPARED TO A WITNESS WHICH HAS NOT BEEN IN CONTACT WITH THE ANTIBODY ALLOWS THE IDENTIFICATION OF CELLS INFECTED WITH THE KNOWN VIRUS. APPLICATION IN PARTICULAR TO THE SIMPLE AND QUICK DIAGNOSIS OF VIRAL INFECTIONS.

FR7926072A 1978-10-19 1979-10-19 REAGENT ASSEMBLY AND METHOD FOR IDENTIFYING VIRAL INFECTIONS Granted FR2439233A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95271978A 1978-10-19 1978-10-19
US7943879A 1979-09-27 1979-09-27

Publications (2)

Publication Number Publication Date
FR2439233A1 true FR2439233A1 (en) 1980-05-16
FR2439233B1 FR2439233B1 (en) 1985-03-08

Family

ID=26762008

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7926072A Granted FR2439233A1 (en) 1978-10-19 1979-10-19 REAGENT ASSEMBLY AND METHOD FOR IDENTIFYING VIRAL INFECTIONS

Country Status (5)

Country Link
CA (1) CA1127536A (en)
DE (1) DE2941575A1 (en)
FR (1) FR2439233A1 (en)
GB (1) GB2034464B (en)
SE (1) SE7908656L (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0105221A1 (en) * 1982-09-07 1984-04-11 Yeda Research And Development Company, Ltd. Process for the determination of interferon and kit for the assay of interferon
EP0143107A1 (en) * 1983-10-26 1985-06-05 Jürgen Dr. Lembke Method for the detection of viruses in pure cultures of microscopic organisms, as well as in foodstuffs and in technological products

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE466623B (en) * 1989-06-01 1992-03-09 Karobio Ab SET AND TEST KIT FOR DIAGNOSTICATION OF AN ACTIVE INFECTION
GB8919230D0 (en) * 1989-08-24 1989-10-04 Vaccine Research Foundation Li Method for in vivo testing of immunity in non-human subjects

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2206859A5 (en) * 1972-11-06 1974-06-07 Pharmacia Ab
FR2334108A2 (en) * 1972-06-26 1977-07-01 Gen Electric DIAGNOSTIC TEST FOR ANTIBODY DETECTION

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2334108A2 (en) * 1972-06-26 1977-07-01 Gen Electric DIAGNOSTIC TEST FOR ANTIBODY DETECTION
FR2206859A5 (en) * 1972-11-06 1974-06-07 Pharmacia Ab

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0105221A1 (en) * 1982-09-07 1984-04-11 Yeda Research And Development Company, Ltd. Process for the determination of interferon and kit for the assay of interferon
EP0143107A1 (en) * 1983-10-26 1985-06-05 Jürgen Dr. Lembke Method for the detection of viruses in pure cultures of microscopic organisms, as well as in foodstuffs and in technological products

Also Published As

Publication number Publication date
GB2034464A (en) 1980-06-04
GB2034464B (en) 1983-05-25
SE7908656L (en) 1980-04-20
CA1127536A (en) 1982-07-13
FR2439233B1 (en) 1985-03-08
DE2941575A1 (en) 1980-04-30

Similar Documents

Publication Publication Date Title
Bouvet et al. Vaginal pH neutralization by semen as a cofactor of HIV transmission
HK7093A (en) Isolation of proteins of htlv-iii,serological detection of antibodies to htlv-iii in sera of patients with aids and pre-aids conditions,and detection of htlv-iii infection by immuno-assays using htlv-iii and its proteins
NZ191317A (en) Immunological determination of immuno-complexes diagnostic agent
ES481208A1 (en) Insolubilized methylated albumin conjugates for autoimmune disease fluoroimmunoassays.
DK174032B1 (en) Kit as well as immunometric dosing method that can be applied to whole cells
EA199800460A1 (en) DIAGNOSTICS AND MEDIATORS OF INFLAMMATORY DISORDERS
FR2439233A1 (en) REAGENT ASSEMBLY AND METHOD FOR IDENTIFYING VIRAL INFECTIONS
FR2396976A1 (en) METHOD OF DOSING CORTISOL WITHOUT EXTRACTION
Fekadu et al. Use of the avidin-biotin peroxidase system to detect rabies antigen in formalin-fixed paraffin-embedded tissues
ES511156A0 (en) A METHOD OF DETERMINING THE PRESENCE OF AN ANTIGEN IN A LIQUID MEDIUM SUSPECTED TO CONTAIN IT.
EP0248534A3 (en) Method of detecting aids virus infection
DE3850249D1 (en) DETECTION OF ANALYTES IN SAMPLE CONTAINING PARTICLES.
Edwards et al. Experimental infectious bovine rhinotracheitis: comparison of four antigen detection methods
FI922666A0 (en) DIAGNOSTIC FOERFARANDE.
SE8302329L (en) T-CELL LEUKEMI ANTIGENS, SET FOR PREPARATION THEREOF AND FOR ANALYTICAL ANTIBODY ANALYSIS
DE69903380D1 (en) Reagent and method for permeabilization and identification of erythrocytes
EP0260599A3 (en) Method and agent for detecting antibodies against human and animal retroviruses, especially t-lymphotropic viruses
KR850008620A (en) Methods and reagents for measuring ATL virus antibodies
Jayakumar et al. A dipstick dot enzyme immunoassay for detection of rabies antigen
SE8101404L (en) REAGENTS AND SETS FOR DETERMINING ALDOLAS OF HUMAN MUSCLE TYPE
Okeke et al. Factors Affecting The Indirect Immunoperoxidase Staining Of Infectious Bursal Disease Virus Antigens In Cells
AU5743198A (en) Method and composition for the diagnosis of equine infectious anemia virus disease by using the recombinant capsid protein virus (p26)
Xu Experimental Study on Enzyme-Labeled Antibody and Enzyme-Labeled SpA Staining Tests for Rapid Detection of Capsule Antibody in Patients With Anthrax.
FR2542871B1 (en) METHOD FOR ASSAYING HETEROGENEOUS PHASE OF ANTIGENIC BIOLOGICAL SUBSTANCES, USING HYBRID CONJUGATES OF ANTIBODIES AND REAGENTS FOR ITS IMPLEMENTATION
JPS5772063A (en) Detection method for hepatitis b virus e antigen

Legal Events

Date Code Title Description
ST Notification of lapse